The Cost-Effectiveness of Human Immunodeficiency Virus Testing and Treatment Engagement Initiatives in British Columbia, Canada: 2011–2013 | Zendy

Bohdan Nosyk | Zendy; Jeong Eun Min | Zendy; Emanuel Krebs | Zendy; Xiao Zang | Zendy; Miranda Compton | Zendy; Réka Gustafson | Zendy; Rolando Barrios | Zendy; Julio Montaner | Zendy; Patty Daly | Zendy; Perry Kendall | Zendy; Gina McGowan | Zendy; Irene S. Day | Zendy; Kate Heath | Zendy; Robert S. Hogg | Zendy

Open Access

The Cost-Effectiveness of Human Immunodeficiency Virus Testing and Treatment Engagement Initiatives in British Columbia, Canada: 2011–2013

Author(s) -

Bohdan Nosyk,

Jeong Eun Min,

Emanuel Krebs,

Xiao Zang,

Miranda Compton,

Réka Gustafson,

Rolando Barrios,

Julio Montaner,

Patty Daly,

Perry Kendall,

Gina McGowan,

Irene S. Day,

Kate Heath,

Robert S. Hogg

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix832

Subject(s) - medicine , psychological intervention , cost effectiveness , cohort , marginal cost , health care , demography , gerontology , nursing , risk analysis (engineering) , sociology , economics , microeconomics , economic growth

Recognition of the secondary preventive benefits of antiretroviral therapy (ART) has mobilized global efforts to "seek, test, treat, and retain" people living with human immunodeficiency virus [HIV]/AIDS (PLHIV) in HIV care. We aimed to determine the cost-effectiveness of a set of HIV testing and treatment engagement interventions initiated in British Columbia, Canada, in 2011-2013.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research